About Orphan Drug and the "CASPIAN" - The FDA has granted an orphan drug designation to “Durvalumab” (“Imfinzi”) for the treatment of patients with small cell lung cancer, SCLC. Data…
About the approval, the studies and the drug, entrectinib - The first regulatory approval has been granted to entrectinib (Rozlytrek) in Japan for the treatment of adult and pediatric patients…
The study and treatment At the World Congress on Gastrointestinal Cancer, held in Barcelona, Spain, on July 3-6, 2019, updated results from a study of 663 metastatic colorectal cancer patients…
The best management for any patient with cancer is receiving the most innovative cancer drugs in advanced stages of development. There, the hope and chances to live longer go far…
A new drug called Entrectinib for the treatment of children and adults with cancer that has recurred or is resistant to treatment, including brain cancers About Entrectinib - Entectinib is…
About “Kadcyla”, Ado-trastuzumab emtansine and HER2-Amplified Advanced Salivary Gland Cancer, SGC - Ado-trastuzumab emtansine, more commonly known as T-DM1 and sold under the trade name “Kadcyla”, is a HER2 targeted antibody-drug…
Background Researchers from Baylor College of Medicine published preliminary findings on the first two patients treated in a Phase I clinical trial, first of its kind in humans, with innovative…
CAR-T against HER2 in advanced Sarcomas The International AACR conference was recently held in the US. The results of a Phase I study were presented in 10 patients with advanced…
Nerlynx in metastatic cervical cancer About a week ago, preliminary results were published in a study examining the efficacy and safety of aN approved drug, called Nerlynx. The study involved…
About A.G. A.G. turned to us about two months ago and told us that her doctor, from a large medical center in the center of the country, was pressing her…